EPIX Essa Pharma Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: EPIX

Price (delayed)

$6.88

Market cap

$304.36M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.59

Enterprise value

$269.13M

as a clinical-stage pharmaceutical company founded on cutting-edge research, essa is focused on developing novel therapeutics for cancer patients. essa embraces innovation not only in our products but also in ...

Highlights
The net income has grown by 21% YoY and by 2.9% from the previous quarter
The EPS has increased by 21% YoY
The company's debt has surged by 111% YoY
EPIX's quick ratio is down by 27% year-on-year and by 5% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://essapharma.com
Peers: OMER OMGA

Key stats

What are the main financial stats of EPIX
Market
Shares outstanding
44.24M
Market cap
$304.36M
Enterprise value
$269.13M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.16
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$25.8M
EBITDA
-$25.69M
Free cash flow
-$21.57M
Per share
EPS
-$0.59
Free cash flow per share
-$0.49
Book value per share
$3.19
Revenue per share
$0
TBVPS
$3.27
Balance sheet
Total assets
$144.49M
Total liabilities
$3.81M
Debt
$374,835
Equity
$140.68M
Working capital
$140.34M
Liquidity
Debt to equity
0
Current ratio
40.75
Quick ratio
40.37
Net debt/EBITDA
1.37
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-17%
Return on equity
-17.4%
Return on invested capital
-23.4%
Return on capital employed
-18.3%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

EPIX stock price

How has the Essa Pharma stock price performed over time
Intraday
-1.01%
1 week
13.16%
1 month
-14%
1 year
141.4%
YTD
4.24%
QTD
-18.96%

Financial performance

How have Essa Pharma's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$31.87M
Net income
-$25.8M
Gross margin
N/A
Net margin
N/A
The net income has grown by 21% YoY and by 2.9% from the previous quarter
EPIX's operating income is up by 11% year-on-year

Growth

What is Essa Pharma's growth rate over time

Valuation

What is Essa Pharma stock price valuation
P/E
N/A
P/B
2.16
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has increased by 21% YoY
The stock's price to book (P/B) is 80% more than its last 4 quarters average of 1.2 but 36% less than its 5-year quarterly average of 3.4
EPIX's equity is down by 13% year-on-year and by 3.4% since the previous quarter

Efficiency

How efficient is Essa Pharma business performance
EPIX's return on invested capital is up by 26% year-on-year
EPIX's ROE is up by 10% YoY
EPIX's return on assets is up by 10% year-on-year

Dividends

What is EPIX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EPIX.

Financial health

How did Essa Pharma financials performed over time
The company's total liabilities rose by 28% YoY and by 9% QoQ
EPIX's quick ratio is down by 27% year-on-year and by 5% since the previous quarter
The company's debt is 100% lower than its equity
The company's debt has surged by 111% YoY
EPIX's equity is down by 13% year-on-year and by 3.4% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.